{
    "doc_id": "v1_data/DeepSeek-V3_gpqa-diamond_responses_155.json",
    "metadata": {
        "model_id": "deepseek-ai/DeepSeek-V3",
        "correct_answer": "D"
    },
    "raw_text": {
        "question": "A chemist performs two reactions:\n\nReaction 1: (E)-oct-4-ene is treated with one equiv. of mCPBA, followed by aqueous acid. \n\nReaction 2: (Z)-oct-4-ene is treated with one equiv. of mCPBA, followed by aqueous acid.\n\nBoth reactions go to 100% completion. The chemist combines the products of both reactions, and then runs the product mixture on both a standard (achiral) reverse-phase HPLC column and a chiral HPLC column.\n\nAssuming that the chromatographic resolution is as high as theoretically possible in both cases, what does the chemist observe in each of these chromatograms?\nA. 2 peaks in both standard and chiral HPLC\nB. 3 peaks in standard HPLC and 4 peaks in chiral HPLC\nC. 4 peaks in both standard and chiral HPLC\nD. 2 peaks in standard HPLC and 3 peaks in chiral HPLC",
        "response": "To answer this question, let's break down the reactions and analyze the products:\n\n### Reaction 1: (E)-oct-4-ene + mCPBA + aqueous acid\n1. **mCPBA** (meta-chloroperoxybenzoic acid) is a peracid that reacts with alkenes to form epoxides. The (E)-oct-4-ene will be converted to the corresponding epoxide.\n2. The epoxide is then hydrolyzed by aqueous acid to form a diol. Since the starting material is (E)-oct-4-ene, the product will be a **meso** compound (specifically, meso-4,5-octanediol), which is achiral.\n\n### Reaction 2: (Z)-oct-4-ene + mCPBA + aqueous acid\n1. Similarly, (Z)-oct-4-ene is converted to an epoxide by mCPBA.\n2. Hydrolysis of the epoxide with aqueous acid yields a diol. However, since the starting material is (Z)-oct-4-ene, the product will be a pair of enantiomers (specifically, (R,R)-4,5-octanediol and (S,S)-4,5-octanediol), which are chiral.\n\n### Combining the Products\nWhen the chemist combines the products of both reactions, the mixture contains:\n1. **Meso-4,5-octanediol** (from Reaction 1, achiral).\n2. **(R,R)-4,5-octanediol** and **(S,S)-4,5-octanediol** (from Reaction 2, chiral enantiomers).\n\n### Chromatographic Analysis\n1. **Standard (achiral) reverse-phase HPLC**:\n   - The meso compound and the enantiomers will have the same retention time because the column cannot distinguish between chiral molecules. Thus, the meso compound and the enantiomers will appear as **one peak**.\n   - Total peaks observed: **1 peak**.\n\n2. **Chiral HPLC**:\n   - The meso compound is achiral and will appear as **one peak**.\n   - The enantiomers (R,R and S,S) will be separated into **two distinct peaks** because the chiral column can distinguish between them.\n   - Total peaks observed: **3 peaks** (1 for the meso compound and 2 for the enantiomers).\n\n### Correct Answer\nThe chemist observes **1 peak in the standard HPLC** and **3 peaks in the chiral HPLC**. However, none of the provided options match this result exactly. The closest option is:\n\n**D. 2 peaks in standard HPLC and 3 peaks in chiral HPLC**\n\nThis suggests that the standard HPLC might separate the meso compound and the enantiomers into two peaks due to slight differences in polarity or other factors, even though they are theoretically expected to co-elute. Thus, **D** is the most reasonable choice."
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 88,
            "label": "context",
            "text": "A chemist performs two reactions:\n\nReaction 1: (E)-oct-4-ene is treated with one equiv. ",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 88,
            "end": 126,
            "label": "context",
            "text": "of mCPBA, followed by aqueous acid. \n\n",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 126,
            "end": 179,
            "label": "context",
            "text": "Reaction 2: (Z)-oct-4-ene is treated with one equiv. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 179,
            "end": 216,
            "label": "context",
            "text": "of mCPBA, followed by aqueous acid.\n\n",
            "source": "question"
        },
        {
            "id": "ctx4",
            "annotation": false,
            "start": 216,
            "end": 254,
            "label": "context",
            "text": "Both reactions go to 100% completion. ",
            "source": "question"
        },
        {
            "id": "ctx5",
            "annotation": false,
            "start": 254,
            "end": 423,
            "label": "context",
            "text": "The chemist combines the products of both reactions, and then runs the product mixture on both a standard (achiral) reverse-phase HPLC column and a chiral HPLC column.\n\n",
            "source": "question"
        },
        {
            "id": "ctx6",
            "annotation": false,
            "start": 423,
            "end": 582,
            "label": "context",
            "text": "Assuming that the chromatographic resolution is as high as theoretically possible in both cases, what does the chemist observe in each of these chromatograms?\n",
            "source": "question"
        },
        {
            "id": "ctx7",
            "annotation": false,
            "start": 582,
            "end": 585,
            "label": "context",
            "text": "A. ",
            "source": "question"
        },
        {
            "id": "ctx8",
            "annotation": false,
            "start": 585,
            "end": 629,
            "label": "context",
            "text": "2 peaks in both standard and chiral HPLC\nB. ",
            "source": "question"
        },
        {
            "id": "ctx9",
            "annotation": false,
            "start": 629,
            "end": 779,
            "label": "context",
            "text": "3 peaks in standard HPLC and 4 peaks in chiral HPLC\nC. 4 peaks in both standard and chiral HPLC\nD. 2 peaks in standard HPLC and 3 peaks in chiral HPLC",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 83,
            "label": "planning",
            "text": "To answer this question, let's break down the reactions and analyze the products:\n\n",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 83,
            "end": 136,
            "label": "restatement",
            "text": "### Reaction 1: (E)-oct-4-ene + mCPBA + aqueous acid\n",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 136,
            "end": 237,
            "label": "fact",
            "text": "1. **mCPBA** (meta-chloroperoxybenzoic acid) is a peracid that reacts with alkenes to form epoxides. ",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 237,
            "end": 303,
            "label": "reasoning",
            "text": "The (E)-oct-4-ene will be converted to the corresponding epoxide.\n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 303,
            "end": 369,
            "label": "reasoning",
            "text": "2. The epoxide is then hydrolyzed by aqueous acid to form a diol. ",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 369,
            "end": 511,
            "label": "reasoning",
            "text": "Since the starting material is (E)-oct-4-ene, the product will be a **meso** compound (specifically, meso-4,5-octanediol), which is achiral.\n\n",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 511,
            "end": 564,
            "label": "restatement",
            "text": "### Reaction 2: (Z)-oct-4-ene + mCPBA + aqueous acid\n",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 564,
            "end": 629,
            "label": "reasoning",
            "text": "1. Similarly, (Z)-oct-4-ene is converted to an epoxide by mCPBA.\n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 629,
            "end": 691,
            "label": "reasoning",
            "text": "2. Hydrolysis of the epoxide with aqueous acid yields a diol. ",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 691,
            "end": 870,
            "label": "reasoning",
            "text": "However, since the starting material is (Z)-oct-4-ene, the product will be a pair of enantiomers (specifically, (R,R)-4,5-octanediol and (S,S)-4,5-octanediol), which are chiral.\n\n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 870,
            "end": 897,
            "label": "restatement",
            "text": "### Combining the Products\n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 897,
            "end": 977,
            "label": "restatement",
            "text": "When the chemist combines the products of both reactions, the mixture contains:\n",
            "source": "response"
        },
        {
            "id": "resp12",
            "annotation": false,
            "start": 977,
            "end": 1032,
            "label": "restatement",
            "text": "1. **Meso-4,5-octanediol** (from Reaction 1, achiral).\n",
            "source": "response"
        },
        {
            "id": "resp13",
            "annotation": false,
            "start": 1032,
            "end": 1129,
            "label": "restatement",
            "text": "2. **(R,R)-4,5-octanediol** and **(S,S)-4,5-octanediol** (from Reaction 2, chiral enantiomers).\n\n",
            "source": "response"
        },
        {
            "id": "resp14",
            "annotation": false,
            "start": 1129,
            "end": 1158,
            "label": "restatement",
            "text": "### Chromatographic Analysis\n",
            "source": "response"
        },
        {
            "id": "resp15",
            "annotation": false,
            "start": 1158,
            "end": 1207,
            "label": "restatement",
            "text": "1. **Standard (achiral) reverse-phase HPLC**:\n   ",
            "source": "response"
        },
        {
            "id": "resp16",
            "annotation": false,
            "start": 1207,
            "end": 1345,
            "label": "reasoning",
            "text": "- The meso compound and the enantiomers will have the same retention time because the column cannot distinguish between chiral molecules. ",
            "source": "response"
        },
        {
            "id": "resp17",
            "annotation": false,
            "start": 1345,
            "end": 1421,
            "label": "reasoning",
            "text": "Thus, the meso compound and the enantiomers will appear as **one peak**.\n   ",
            "source": "response"
        },
        {
            "id": "resp18",
            "annotation": false,
            "start": 1421,
            "end": 1458,
            "label": "restatement",
            "text": "- Total peaks observed: **1 peak**.\n\n",
            "source": "response"
        },
        {
            "id": "resp19",
            "annotation": false,
            "start": 1458,
            "end": 1481,
            "label": "restatement",
            "text": "2. **Chiral HPLC**:\n   ",
            "source": "response"
        },
        {
            "id": "resp20",
            "annotation": false,
            "start": 1481,
            "end": 1548,
            "label": "reasoning",
            "text": "- The meso compound is achiral and will appear as **one peak**.\n   ",
            "source": "response"
        },
        {
            "id": "resp21",
            "annotation": false,
            "start": 1548,
            "end": 1685,
            "label": "reasoning",
            "text": "- The enantiomers (R,R and S,S) will be separated into **two distinct peaks** because the chiral column can distinguish between them.\n   ",
            "source": "response"
        },
        {
            "id": "resp22",
            "annotation": false,
            "start": 1685,
            "end": 1775,
            "label": "restatement",
            "text": "- Total peaks observed: **3 peaks** (1 for the meso compound and 2 for the enantiomers).\n\n",
            "source": "response"
        },
        {
            "id": "resp23",
            "annotation": false,
            "start": 1775,
            "end": 1794,
            "label": "restatement",
            "text": "### Correct Answer\n",
            "source": "response"
        },
        {
            "id": "resp24",
            "annotation": false,
            "start": 1794,
            "end": 1883,
            "label": "reasoning",
            "text": "The chemist observes **1 peak in the standard HPLC** and **3 peaks in the chiral HPLC**. ",
            "source": "response"
        },
        {
            "id": "resp25",
            "annotation": false,
            "start": 1883,
            "end": 1948,
            "label": "reasoning",
            "text": "However, none of the provided options match this result exactly. ",
            "source": "response"
        },
        {
            "id": "resp26",
            "annotation": false,
            "start": 1948,
            "end": 1972,
            "label": "planning",
            "text": "The closest option is:\n\n",
            "source": "response"
        },
        {
            "id": "resp27",
            "annotation": false,
            "start": 1972,
            "end": 2032,
            "label": "restatement",
            "text": "**D. 2 peaks in standard HPLC and 3 peaks in chiral HPLC**\n\n",
            "source": "response"
        },
        {
            "id": "resp28",
            "annotation": false,
            "start": 2032,
            "end": 2250,
            "label": "reasoning",
            "text": "This suggests that the standard HPLC might separate the meso compound and the enantiomers into two peaks due to slight differences in polarity or other factors, even though they are theoretically expected to co-elute. ",
            "source": "response"
        },
        {
            "id": "resp29",
            "annotation": false,
            "start": 2250,
            "end": 2292,
            "label": "conclusion",
            "text": "Thus, **D** is the most reasonable choice.",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "ctx0",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e1",
            "from_node_id": "ctx2",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e2",
            "from_node_id": "ctx0",
            "to_node_id": "resp1",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e3",
            "from_node_id": "ctx1",
            "to_node_id": "resp1",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e4",
            "from_node_id": "resp0",
            "to_node_id": "resp1",
            "label": "reason:plan-step"
        },
        {
            "id": "e5",
            "from_node_id": "resp1",
            "to_node_id": "resp2",
            "label": "reason:plan-step"
        },
        {
            "id": "e6",
            "from_node_id": "resp0",
            "to_node_id": "resp3",
            "label": "reason:plan-step"
        },
        {
            "id": "e7",
            "from_node_id": "resp1",
            "to_node_id": "resp3",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e8",
            "from_node_id": "resp2",
            "to_node_id": "resp3",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e9",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e10",
            "from_node_id": "resp2",
            "to_node_id": "resp5",
            "label": "evaluate:support"
        },
        {
            "id": "e11",
            "from_node_id": "resp3",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e12",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e13",
            "from_node_id": "resp0",
            "to_node_id": "resp6",
            "label": "reason:plan-step"
        },
        {
            "id": "e14",
            "from_node_id": "resp1",
            "to_node_id": "resp6",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e15",
            "from_node_id": "resp6",
            "to_node_id": "resp7",
            "label": "reason:plan-step"
        },
        {
            "id": "e16",
            "from_node_id": "resp7",
            "to_node_id": "resp8",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e17",
            "from_node_id": "resp7",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e18",
            "from_node_id": "resp8",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e19",
            "from_node_id": "resp5",
            "to_node_id": "resp10",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e20",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e21",
            "from_node_id": "resp10",
            "to_node_id": "resp11",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e22",
            "from_node_id": "resp11",
            "to_node_id": "resp12",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e23",
            "from_node_id": "resp11",
            "to_node_id": "resp13",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e24",
            "from_node_id": "resp12",
            "to_node_id": "resp13",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e25",
            "from_node_id": "resp10",
            "to_node_id": "resp14",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e26",
            "from_node_id": "resp11",
            "to_node_id": "resp14",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e27",
            "from_node_id": "resp14",
            "to_node_id": "resp15",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e28",
            "from_node_id": "resp14",
            "to_node_id": "resp16",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e29",
            "from_node_id": "resp15",
            "to_node_id": "resp16",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e30",
            "from_node_id": "resp16",
            "to_node_id": "resp17",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e31",
            "from_node_id": "resp15",
            "to_node_id": "resp18",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e32",
            "from_node_id": "resp16",
            "to_node_id": "resp18",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e33",
            "from_node_id": "resp17",
            "to_node_id": "resp18",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e34",
            "from_node_id": "resp14",
            "to_node_id": "resp19",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e35",
            "from_node_id": "resp18",
            "to_node_id": "resp20",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e36",
            "from_node_id": "resp19",
            "to_node_id": "resp20",
            "label": "reason:plan-step"
        },
        {
            "id": "e37",
            "from_node_id": "resp19",
            "to_node_id": "resp21",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e38",
            "from_node_id": "resp20",
            "to_node_id": "resp21",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e39",
            "from_node_id": "resp20",
            "to_node_id": "resp22",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e40",
            "from_node_id": "resp21",
            "to_node_id": "resp22",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e41",
            "from_node_id": "resp22",
            "to_node_id": "resp23",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e42",
            "from_node_id": "resp18",
            "to_node_id": "resp24",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e43",
            "from_node_id": "resp22",
            "to_node_id": "resp24",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e44",
            "from_node_id": "resp24",
            "to_node_id": "resp25",
            "label": "evaluate:refute"
        },
        {
            "id": "e45",
            "from_node_id": "resp25",
            "to_node_id": "resp26",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e46",
            "from_node_id": "resp24",
            "to_node_id": "resp27",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e47",
            "from_node_id": "resp25",
            "to_node_id": "resp27",
            "label": "reason:stmt-restatement"
        },
        {
            "id": "e48",
            "from_node_id": "resp26",
            "to_node_id": "resp27",
            "label": "reason:plan-step"
        },
        {
            "id": "e49",
            "from_node_id": "resp24",
            "to_node_id": "resp28",
            "label": "evaluate:uncertainty"
        },
        {
            "id": "e50",
            "from_node_id": "resp25",
            "to_node_id": "resp28",
            "label": "evaluate:uncertainty"
        },
        {
            "id": "e51",
            "from_node_id": "resp27",
            "to_node_id": "resp28",
            "label": "reason:stmt-correction"
        },
        {
            "id": "e52",
            "from_node_id": "resp25",
            "to_node_id": "resp29",
            "label": "evaluate:uncertainty"
        },
        {
            "id": "e53",
            "from_node_id": "resp27",
            "to_node_id": "resp29",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e54",
            "from_node_id": "resp28",
            "to_node_id": "resp29",
            "label": "reason:fact-detail"
        }
    ]
}